Asset
Selcodebart
Disc Medicine Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05320198 | phase1_2 | recruiting | 2022-06-06 | 2027-05-01 | Disc Medicine, Inc | Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia |
| NCT05745883 | phase1 | completed | 2023-04-04 | 2025-10-09 | Disc Medicine, Inc | Study of DISC-0974 to Assess the Safety, Tolerability, PK and PD of DISC-0974 in Participants With CKD and Anemia |
| NCT07368972 | phase2 | recruiting | 2026-02-20 | 2026-10-01 | Disc Medicine, Inc | Study of DISC-0974-201 in Participants With IBD and Anemia |
| NCT04999527 | phase1 | completed | 2021-08-10 | 2022-06-30 | Disc Medicine, Inc | Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects |
FDA applications (0)
This company has no applications containing this asset.